Brexit At The 11th Hour: UK Refreshes No-Deal Guidance For Medtech
Executive Summary
With the UK still wallowing in uncertainty over Brexit, the government has been forced hit the ground running in January by issuing various documents spelling out in greater detail what will need to happen in the case of a "no-deal" Brexit, which is looking increasingly possible. What does medtech need to know?
You may also be interested in...
Medical Device Registration In UK Under A No-Deal Brexit: Questions Answered
The UK government is introducing new registration requirements for medical devices in the event of a no-deal Brexit. They will be rolled out according to the risk class of products. But some fundamental questions have arisen.
How To Read The UK’s New Medical Device Regulations: MHRA Explains The Main Points
The UK’s 2019 medtech regulations laid in Parliament last week in preparation for a possible no-deal Brexit at the end of March are long and difficult to read. Medtech Insight spoke to the Medicines and Healthcare products Regulatory Agency to find out the essentials.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.